Vera Therapeutics Inc (VERA)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $2.03B
Last updated: Nov 17, 2026 at 11:05 AM ET
Vera Therapeutics Inc (VERA) Competitors
The companies most similar to Vera Therapeutics are Vir Biotechnology (VIR), Vericel Corp Ord (VCEL) and Trevi Therapeutics (TRVI). By market cap, Vera Therapeutics ranks 7th of the 13 companies on this page; Travere Therapeutics (TVTX) is the largest at $4.86B.
Peer Comparison
VERA's ROIC of -83.0% is below the peer median of -29.7%, and its revenue growth of 0.0% is in line with the median. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| Vera Therapeutics (VERA) | $2.03B | N/A | 189.3x | 0.0% | -83.0% | 0.0% | 0.00% |
| Vir Biotechnology Inc (VIR) | $1.71B | N/A | 5.4x | -61.0% | N/A | 19582.0% | 0.00% |
| Vericel Corp Ord (VCEL) | $2.91B | 89.8x | 9.1x | 10.3% | N/A | 26.5% | 0.00% |
| Trevi Therapeutics Inc (TRVI) | $1.95B | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Structure Therapeutics Inc. American Depositary Shares (GPCR) | $1.43B | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Beam Therapeutics Inc (BEAM) | $2.36B | N/A | 15.0x | -73.9% | -29.7% | -96.8% | 0.00% |
| Pharvaris BV (PHVS) | $2.36B | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Viridian Therapeutics Inc (VRDN) | $3.51B | N/A | 128.5x | 0.0% | -41.8% | -63.5% | 0.00% |
| Travere Therapeutics Inc (TVTX) | $4.86B | N/A | 7.2x | -18.7% | -23.1% | 36.2% | 0.00% |
| Nurix Therapeutics Inc (NRIX) | $1.69B | 6.4x | 2.3x | 42.0% | N/A | 8426.0% | 0.00% |
| Viking Therapeutics Inc (VKTX) | $3.73B | N/A | N/A | 0.0% | -61.0% | 0.0% | 0.00% |
| Sarepta Therapeutics Inc (SRPT) | $1.72B | N/A | 0.8x | -5.9% | -3.2% | -4.5% | 0.00% |
| Tyra Biosciences Inc (TYRA) | $1.38B | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Peer median | $2.15B | 48.1x | 7.2x | 0.0% | -29.7% | 0.0% | 0.00% |
Similar Companies
These are the 12 companies most similar to Vera Therapeutics, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.
| Company | About | Peers |
|---|---|---|
| Vir Biotechnology Inc (VIR) | Vir Biotechnology, Inc., a clinical-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. | VIR competitors |
| Vericel Corp Ord (VCEL) | Vericel Corporation, a commercial-stage biopharmaceutical company, researches, develops, manufactures... | VCEL competitors |
| Trevi Therapeutics Inc (TRVI) | Trevi Therapeutics, Inc., a clinical-stage biopharmaceutical company, is focused on the development and commercialization of Haduvio to treat serious... | TRVI competitors |
| Structure Therapeutics Inc. American Depositary Shares (GPCR) | Structure Therapeutics Inc., a clinical stage global biopharmaceutical company, develops and delivers novel oral therapeutics to treat a range of chronic... | GPCR competitors |
| Beam Therapeutics Inc (BEAM) | Beam Therapeutics Inc., a biotechnology company, develops precision genetic drugs for patients with serious illnesses in the United States. | BEAM competitors |
| Pharvaris BV (PHVS) | Pharvaris NV, a clinical-stage biopharmaceutical company, focuses on the development and commercialization of rare disease therapies. | PHVS competitors |
| Viridian Therapeutics Inc (VRDN) | Viridian Therapeutics, Inc., a biotechnology company, develops treatments for patients with serious illnesses. | VRDN competitors |
| Travere Therapeutics Inc (TVTX) | Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification... | TVTX competitors |
| Nurix Therapeutics Inc (NRIX) | Nurix Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development... | NRIX competitors |
| Viking Therapeutics Inc (VKTX) | Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, is focused on developing new therapies for metabolic and endocrine disorders. | VKTX competitors |
| Sarepta Therapeutics Inc (SRPT) | Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapies, gene therapy... | SRPT competitors |
| Tyra Biosciences Inc (TYRA) | Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and improve outcomes... | TYRA competitors |
Frequently Asked Questions About VERA
Who are Vera Therapeutics' main competitors?
The companies most similar to Vera Therapeutics include Vir Biotechnology (VIR), Vericel Corp Ord (VCEL), Trevi Therapeutics (TRVI), Structure Therapeutics Inc. American Depositary Shares (GPCR) and Beam Therapeutics (BEAM), listed from the closest match.
Who is Vera Therapeutics' biggest competitor?
Travere Therapeutics (TVTX) is the largest of the similar companies at $4.86B; Vir Biotechnology (VIR) is the closest match by business profile, size, sector and industry.
How does VERA stock compare with its competitors?
VERA's P/S is 189.3x against a peer median of 7.2x; its net margin is 0.0% against a peer median of 0.0%.
Which of Vera Therapeutics' competitors pays a higher dividend?
Vera Therapeutics pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.
Is Vera Therapeutics bigger than its competitors?
No. Vera Therapeutics is 7th by market cap among the 13 companies on this page; the largest is Travere Therapeutics (TVTX) at $4.86B.
VERA pages: Overview, Earnings, Forecast, Financials, Competitors